Neoadjuvant Chemoradiotherapy in Rectal Cancer: Are there New Drug Combinations on the Horizon? (CROSBI ID 790021)
Druge vrste radova | ostalo
Podaci o odgovornosti
Reinhold Arnold Cristoph, Mangesius Julian, Jäger Robert, Ganswindt Ute
engleski
Neoadjuvant Chemoradiotherapy in Rectal Cancer: Are there New Drug Combinations on the Horizon?
SummaryNeoadjuvant chemoradiotherapy is a well-established standard treatment for locally advancedrectal cancer and has led to a remarkable improve-ment in local control. However, distant recurrencesstill pose a notable threat and local failure, albeit in-creasingly rare, can lead to unfavorable clinical situ-ations. In this short review, we discuss three promis-ing new strategies to improve rectal cancer treatment:total neoadjuvant therapy, short course radiotherapy, and immune checkpoint inhibitors.
rectal cancer, neoadjuvant treatment
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
MEMO
2020.
nije evidentirano
objavljeno